Primary clear cell adenocarcinoma of the rectovaginal septum treated with concurrent chemoradiation therapy: A case report

M. Guiou, W. H. Hall, Thomas Konia, Sidney A Scudder, Gary S Leiserowitz, J. K. Ryu

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Primary clear cell adenocarcinoma of the rectovaginal septum is rare and typically emerges in the setting of endometriosis. We report a case of a 52-year-old woman with clear cell adenocarcinoma of the rectovaginal septum presenting with vaginal hemorrhage. Management with concurrent chemoradiation with cisplatin and paclitaxel is discussed. Six years following the completion of treatment, the patient is without evidence of disease or significant long-term toxicity.

Original languageEnglish (US)
Pages (from-to)1118-1121
Number of pages4
JournalInternational Journal of Gynecological Cancer
Volume18
Issue number5
DOIs
StatePublished - Sep 2008

Keywords

  • Chemoradiation
  • Clear cell
  • Rectovaginal septum

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Primary clear cell adenocarcinoma of the rectovaginal septum treated with concurrent chemoradiation therapy: A case report'. Together they form a unique fingerprint.

  • Cite this